0000904454-13-000832.txt : 20130725
0000904454-13-000832.hdr.sgml : 20130725
20130725130044
ACCESSION NUMBER: 0000904454-13-000832
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130715
FILED AS OF DATE: 20130725
DATE AS OF CHANGE: 20130725
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001274644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 631192270
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12651 HIGH BLUFF DRIVE
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-436-3900
MAIL ADDRESS:
STREET 1: 12651 HIGH BLUFF DRIVE
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: TRANZYME INC
DATE OF NAME CHANGE: 20031230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halak Brian K
CENTRAL INDEX KEY: 0001354718
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35119
FILM NUMBER: 13985704
MAIL ADDRESS:
STREET 1: C/O DOMAIN ASSOCIATES
STREET 2: ONE PALMER SQUARE
CITY: PRINCETON
STATE: NJ
ZIP: 08542
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2013-07-15
2013-07-16
0001274644
Ocera Therapeutics, Inc.
OCRX
0001354718
Halak Brian K
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
0
0
1
0
Common Stock
2013-07-15
4
P
0
988285
6.0264
A
988285
I
By Domain Partners VIII, L.P.
Common Stock
2013-07-15
4
P
0
7333
6.0264
A
7333
I
By DP VIII Associates, L.P.
Common Stock
47963
I
By Domain Associates, LLC
The Reporting Person is a Managing Member of (i) One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. and (ii) Domain Associates, LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
This amendment to Form 4 is being filed to correct an error in the original filing, which indicated that the Reporting Person is also a Managing Member of One Palmer Square Associates VI, LLC, the sole general partner of Domain Partners VI, L.P. and DP VI Associates, L.P. The Reporting Person is not a Managing Member of One Palmer Square Associates VI, LLC.
The Issuer changed its name from Tranzyme, Inc. [TZYM] to Ocera Therapeutics, Inc. on July 15, 2013.
/s/Kathleen K. Schoemaker, Attorney-in-Fact
2013-07-25